Trials / Conditions / Schistosoma Mansoni

Schistosoma Mansoni

10 registered clinical trials studyying Schistosoma Mansoni.

Status	Trial	Sponsor	Phase
Unknown	Sm-p80 Schistosomiasis Challenge Study NCT05999825	Leiden University Medical Center	Phase 2
Completed	Repeated Controlled Human Schistosoma Mansoni Infection NCT05085470	Leiden University Medical Center	N/A
Completed	Clinical Evaluation of Ujiplus® Against Schistosoma Mansoni NCT04679831	Kenya Medical Research Institute	Phase 2 / Phase 3
Unknown	Filling Key Research Gaps With Clinical Implications in Mansonellosis and Schistosomiasis: a Network Approach NCT06311344	IRCCS Sacro Cuore Don Calabria di Negrar	N/A
Completed	Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children NCT03893097	Institute of Tropical Medicine, Belgium	Phase 3
Completed	Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults NCT03910972	Baylor College of Medicine	Phase 1 / Phase 2
Completed	Single-sex Controlled Human Schistosomiasis Infection: Safety and Dose Finding NCT02755324	Leiden University	N/A
Withdrawn	Leiden University Medical Center Mini Donor Bank NCT02810613	Leiden University Medical Center	—
Completed	Schistosoma Mansoni in Mwanza Region, Tanzania NCT02162875	DBL -Institute for Health Research and Development	N/A
Completed	A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S NCT01054651	Kenya Medical Research Institute	Phase 3